35.3 Urinary Analgesics

Urinary Analgesics

Urinary analgesics relieve pain and discomfort in the lower urinary tract. They don't treat the underlying cause of a urinary condition, but they make symptoms like dysuria, urgency, and frequency much more tolerable while the primary treatment takes effect.

Key Features and Uses

Urinary analgesics are prescribed for bladder pain and discomfort associated with conditions such as urinary tract infections (UTIs), interstitial cystitis (IC), and painful bladder syndrome (PBS). They work by targeting the urinary tract lining directly, either numbing it or protecting it from further irritation.

The two drugs you need to know in this category serve different purposes:

• Phenazopyridine (Pyridium) provides short-term symptomatic relief of UTI-related pain. It's typically used for only 2 days alongside an antibiotic, not as a standalone treatment.
• Pentosan polysulfate sodium (Elmiron) is specifically indicated for interstitial cystitis. It's a longer-term therapy that can take weeks to months before patients notice improvement.

Mechanism of Action, Side Effects, and Drug Interactions

Phenazopyridine (Pyridium)

Phenazopyridine is an azo dye that exerts a local analgesic/anesthetic effect on the urinary tract mucosa. It's excreted in the urine, where it acts directly on the inflamed lining to reduce pain, burning, and urgency. It does not treat infection.

• Side effects:
  • Orange-red discoloration of urine (expected and harmless, but patients need to be warned)
  • Can permanently stain soft contact lenses
  • GI upset: nausea, vomiting, diarrhea
  • Headache and dizziness
  • In overdose or prolonged use, can cause methemoglobinemia and hemolytic anemia, especially in patients with renal impairment or G6PD deficiency
• Drug interactions: Use caution with other medications that may affect renal function. The drug is contraindicated in renal insufficiency because impaired excretion increases the risk of toxicity.
• Duration limit: Should not be used for more than 2 days when taken with an antibacterial agent. Prolonged use masks symptoms and increases toxicity risk.

Pentosan Polysulfate Sodium (Elmiron)

Pentosan is a heparin-like compound believed to coat the bladder wall, restoring the protective glycosaminoglycan (GAG) layer. This reduces the contact between urine irritants and the bladder lining, decreasing inflammation and pain over time.

• Side effects:
  • GI upset: diarrhea, nausea, abdominal pain
  • Headache and dizziness
  • Alopecia (hair thinning/loss)
  • Retinal maculopathy with long-term use (a serious concern; patients need baseline and periodic eye exams)
• Drug interactions: Pentosan has mild anticoagulant properties. When combined with anticoagulants (warfarin), antiplatelets, or NSAIDs, bleeding risk increases. Monitor for signs of bleeding.

Nursing Considerations

1. Before administration: Review the patient's medical history, allergies, renal function, and current medication list. Phenazopyridine is contraindicated in renal insufficiency.
2. Assess baseline symptoms: Document pain level, urinary frequency, urgency, and dysuria so you can evaluate whether the drug is working.
3. Monitor for adverse effects: Watch for GI symptoms, CNS effects (dizziness, headache), and signs of bleeding with pentosan. For phenazopyridine, be alert for yellowish skin or sclera, which may indicate accumulation or toxicity rather than the expected urine color change.
4. Administer with food to reduce GI upset, when appropriate.
5. Track duration of therapy: For phenazopyridine, confirm the patient is not exceeding the recommended 2-day course. For pentosan, set expectations that therapeutic effects may take 3 to 6 months.

Patient Education

• Phenazopyridine will turn your urine orange-red. This is expected and not blood. Warn patients to avoid wearing soft contact lenses during treatment because the dye can stain them permanently.
• Take the medication with food to reduce nausea.
• Do not take phenazopyridine longer than prescribed. If UTI symptoms persist beyond 2 days, the patient should contact their provider rather than continue the analgesic.
• Stay hydrated. Encourage drinking plenty of water. Advise patients to limit or avoid caffeine, alcohol, and spicy foods, which can irritate the bladder and worsen symptoms.
• Report concerning symptoms promptly: severe GI distress, unusual bruising or bleeding (especially with pentosan), skin or eye yellowing, or vision changes.
• Disclose all medications to the healthcare provider, including OTC drugs and supplements, to avoid interactions.
• Keep follow-up appointments to monitor treatment progress, especially for patients on long-term pentosan therapy who need periodic eye exams.